当前位置:首页 - 行情中心 - 惠泰医疗(688617) - 财务分析

惠泰医疗

(688617)

  

流通市值:362.84亿  总市值:362.84亿
流通股本:1.41亿   总股本:1.41亿

惠泰医疗(688617)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年年度实现净利润8.08亿元,每股收益5.82元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年年度最新股东权益313034.94万元,未分配利润229040.97万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年年度最新总资产365185.66万元,负债52150.73万元。

利润表
报告期2025-12-312025-09-302025-06-302025-03-31
营业总收入2,583,927,321.091,867,437,461.291,213,804,906.53564,276,710.67
营业总成本1,672,065,165.221,191,415,119.57752,300,167.35357,739,406.5
其他经营收益
营业利润944,558,555.84710,662,982.14483,304,979.16215,668,911.8
利润总额936,290,399.51705,751,543.8479,340,286.62213,819,515.86
净利润807,739,206.52614,819,029.79418,900,671.88180,135,141.87
每股收益
其他综合收益406,783.214,244,439.092,191,973.46-138,078.4
综合收益总额808,145,989.73619,063,468.88421,092,645.34179,997,063.47
资产负债表
报告期2025-12-312025-09-302025-06-302025-03-31
流动资产:
流动资产合计2,122,233,847.441,978,815,743.521,781,575,753.241,750,830,787.65
非流动资产:
非流动资产合计1,529,622,799.641,481,937,296.441,440,924,761.171,393,761,981.58
资产总计3,651,856,647.083,460,753,039.963,222,500,514.413,144,592,769.23
流动负债:
流动负债合计458,960,421.29367,679,331.39348,102,859.99371,231,509.51
非流动负债:
非流动负债合计62,546,856.6355,823,394.6645,117,968.0736,906,749.14
负债合计521,507,277.92423,502,726.05393,220,828.06408,138,258.65
所有者权益(或股东权益):
归属于母公司股东权益合计3,088,667,057.762,988,822,083.242,794,367,389.652,700,953,801.47
股东权益合计3,130,349,369.163,037,250,313.912,829,279,686.352,736,454,510.58
负债和股东权益合计3,651,856,647.083,460,753,039.963,222,500,514.413,144,592,769.23
现金流量表
报告期2025-12-312025-09-302025-06-302025-03-31
经营活动产生的现金流量:
经营活动现金流入小计2,974,884,678.512,143,203,311.231,398,374,210.86661,666,868.33
经营活动现金流出小计2,007,125,019.731,467,144,111.77953,725,557.93495,004,280.84
经营活动产生的现金流量净额967,759,658.78676,059,199.46444,648,652.93166,662,587.49
投资活动产生的现金流量:
投资活动现金流入小计2,523,194,329.391,735,713,312.31,212,932,925.25696,565,764.86
投资活动现金流出小计3,042,376,718.212,329,491,613.41,478,864,010.4744,584,702.92
投资活动产生的现金流量净额-519,182,388.82-593,778,301.1-265,931,085.15-48,018,938.06
筹资活动产生的现金流量:
筹资活动现金流入小计54,936,123.8143,776,853.7827,373,979.28-
筹资活动现金流出小计334,680,002.8231,415,118.32224,066,169.412,856,896.05
筹资活动产生的现金流量净额-279,743,878.99-187,638,264.54-196,692,190.13-2,856,896.05
汇率变动对现金及现金等价物的影响-3,790,697.36-876,175.642,149,549.56799,616.44
现金及现金等价物净增加额165,042,693.61-106,233,541.82-15,825,072.79116,586,369.82
期末现金及现金等价物余额1,246,130,604.64974,854,369.211,065,262,838.241,197,674,280.85
补充资料:
现金及现金等价物的净增加额165,042,693.61--15,825,072.79-
最新报告期:2026-03-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西南证券杜向阳7.389.0311.282026-03-28
中金公司俞波,张琎7.148.75--2026-03-26
华泰证券代雯,高鹏,杨昌源7.399.3711.752026-03-25
方正证券许睿,周超泽7.469.3511.542026-03-25
国信证券彭思宇,陈曦炳7.759.9212.412026-03-25
TOP↑